Challenges and opportunities in animal drug development: a regulatory perspective.
Lathers
Claire M
CM
Center for Veterinary Medicine, Food and Drug Administration, Office of the Director, Rockville, MD 20855, USA. lathers@attglobal.net
D000827:Animal Welfare; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001168:Arthritis / Q000188:drug therapy / Q000662:veterinary; D001682:Biological Availability; D004283:Dog Diseases / Q000188:drug therapy; D004285:Dogs; D006801:Humans; D013045:Species Specificity; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration; D019155:Veterinary Drugs / Q000009:adverse effects / Q000493:pharmacokinetics
D000894:Anti-Inflammatory Agents, Non-Steroidal; D019155:Veterinary Drugs